NEUCA S.A. (FRA:7HD)

Market Cap	801.00M +9.3%
Revenue (ttm)	3.29B +8.4%
Net Income	45.71M +45.1%
EPS	9.95 +43.7%
Shares Out	n/a
PE Ratio	17.52
Forward PE	16.36
Dividend	4.15 (2.46%)
Ex-Dividend Date	Jun 29, 2026

Volume	n/a
Open	168.80
Previous Close	167.00
Day's Range	168.80 - 168.80
52-Week Range	147.80 - 199.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1990
• Employees: 5,172
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7HD

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.

Financial numbers in PLN

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 19, 2026

Data Sources Report a data error